Webinars
Enabling Adaptive Clinical Trials through Integrated Development and Manufacturing Solutions
Summary: In this webinar, industry experts will discuss how a manufacturing on-demand strategy can enhance your clinical development and improve drug supply utilization.
View Now
Article
ARCUS®: A Commercialized Technology Enabling High-Dose, Highly Respirable Powders
Summary: In this article, Dr. Alan Watts, Director of Innovation & Partnerships for Orally Inhaled Products at Catalent, and Michael Tauber, Senior Director of Pharmaceutical Development at Acorda Therapeutics discuss the requirements and benefits of using spray-dried powders for inhalation, and how ARCUS can be used to successfully bring new inhaled therapies to market.
View Now
Article
Your Perfect Partner for Dry Powder Inhalation
Summary: This article discusses how to successfully develop and manufacture spray-dried pulmonary and nasal powders and how a CDMO partner plays an integral role in the successful development and commercialization of inhalation products.
View Now
Offering Fact Sheet
Nitrosamine Testing Services
Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.
View Now
Offering Fact Sheet
Catalent Nottingham - European Centre of Excellence for Early Phase Development
Summary: Catalent’s Nottingham facility specializes in early phase development of small molecule drug candidates and complex molecules from bench to clinic through integrated offerings such as...
View Now
Webinars
From Lab to Launch: Successful Drug Development Strategies Using Lipid-Based Formulations and Softgels
Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.
View Now
Webinars
QbD Approach to Small-Scale Studies to Enable Rapid Spray Drying Scale-Up
Industry experts discuss how QbD strategies can be applied in the systematic evaluation of small batches of spray-dried solid dispersions for oral delivery.
View Now
Executive Summary
Preclinical Toxicology vs Clinical: Key Considerations in Using Lipid-Based Formulations
Summary: Download this article to gain insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.
View Now
Executive Summary
Nitrosamines, Elemental Impurities, Extractable and Leachable – A New Normal for the Pharma Industry
Summary: Download this article to learn more about the current regulatory expectations for E&L, elemental impurities and nitrosamines testing, as well as the latest advances in analytical methods.
View Now
Webinars
Navigating Policy, Funding, CMC and Regulatory Dynamics for Successful Orphan Drug Development
During this webinar, industry experts will teach valuable insights, strategies, and practical knowledge to overcome the challenges and pave a successful path to orphan drug development and commercialization.
View Now
